Events & Presentations

Investors
<picture><source type="image/webp" srcSet="/static/2cf241996b0d6d9b54351b76891640b8/18e05/Image-1.webp 740w,/static/2cf241996b0d6d9b54351b76891640b8/81bef/Image-1.webp 1480w,/static/2cf241996b0d6d9b54351b76891640b8/2d0b8/Image-1.webp 2960w" sizes="(min-width: 2960px) 2960px, 100vw"/><img data-gatsby-image-ssr="" data-main-image="" style="opacity:0" sizes="(min-width: 2960px) 2960px, 100vw" decoding="async" loading="lazy" src="/static/2cf241996b0d6d9b54351b76891640b8/c9eb6/Image-1.jpg" srcSet="/static/2cf241996b0d6d9b54351b76891640b8/bbd3f/Image-1.jpg 740w,/static/2cf241996b0d6d9b54351b76891640b8/087e6/Image-1.jpg 1480w,/static/2cf241996b0d6d9b54351b76891640b8/c9eb6/Image-1.jpg 2960w" alt="&lt;p&gt;Close up of a middle aged woman dressed in a blazer, sitting down while looking at another person in the foreground.&lt;/p&gt;
"/></picture>
Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.

Overview
Press releases
Events & presentations
Corporate Governance
Articles of Association
General meeting
Board of Directors
Corporate governance reports
Senior executives
Nomination committee
Remuneration and the remuneration committee
Auditors and audit committee
Scientific committee
Scientific advisory board
Archived transactions
Shareholder & stock info
Share monitor
Shareholders
Convertible bonds
Analyst coverage
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Events & Presentations2023
2023
27 September 2023Upcoming
Nordic Conference and Opening Ceremony of NorthX Innovation Hub
Mendus Board member Hans Preusting will participate at the event.
Learn more
20 September 2023Previous
CICON23 – International Cancer Immunotherapy Conference
Mendus to present preclinical and clinical data on the mode of action of its lead clinical program vididencel.
Learn more
14 September 2023Previous
Pareto Securities’ Annual Healthcare Conference
Mendus CEO Erik Manting and CFO Lotta Ferm will participate and present a Company Update at the conference.
Learn more
11 September 2023Previous
H.C. Wainwright 25th Annual Global Investment Conference
Mendus CEO Erik Manting will participate and present a Company Update at the conference.
Learn more
27 June 2023Previous
Update on vididencel program – Webcast Replay
Mendus provided an update on its lead program vididencel on Tuesday, June 27, 2023. The update took place in an online event and, separately, on-site at the company’s headquarters in Stockholm, Sweden. The replay of the webcast version is accessible via the link below.
Learn more
13 June 2023Previous
Aktiespararna Småbolagsdagarna
Mendus CEO Erik Manting will present on June 13th, 2023 at 16:50 CEST.
Learn more
8 June 2023Previous
EHA2023 Hybrid Congress
Mendus to present updates on immunomonitoring data from ADVANCE II trial and progress on the development of its NK cell therapy program.
Learn more
5 June 2023Previous
BIO International Convention
Erik Manting, CEO of Mendus, will attend the conference.
Learn more
1 June 2023Previous
Redeye Growth Day
Mendus CEO Erik Manting will participate in a live Q&A session on June 1st.
Learn more
8 May 2023Previous
CCBIO’s 11th Annual Symposium
Mendus will present immunomonitoring and research data supporting the mode of action of its lead program vididencel.
Learn more